Abivax Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	780	673	-	-
Enterprise Value	577	465	24	-10
PE Ratio	-	-4.10	-	-
PS Ratio	151.95	131.03	-	-
PB Ratio	3.65	3.09	-	-
P/FCF Ratio	-6.22	-6.22	-	-
P/OCF Ratio	-6.23	-6.23	-	-
EV/Sales Ratio	112.35	90.63	4.86	-0.76
EV/EBITDA Ratio	-3.51	-3.51	-0.42	0.23
EV/EBIT Ratio	-3.49	-3.49	-0.41	0.23
EV/FCF Ratio	-4.30	-4.30	-0.41	0.20
Debt / Equity Ratio	0.38	0.38	6.85	1.99
Debt / EBITDA Ratio	-0.62	-0.62	-0.92	-1.34
Debt / FCF Ratio	-0.76	-0.76	-0.91	-1.15
Quick Ratio	3.73	3.73	0.84	1.88
Current Ratio	4.08	4.08	1.13	2.34
Asset Turnover	0.02	0.02	0.05	-
Interest Coverage	-4.30	-4.30	-7.65	-10.92
Return on Equity (ROE)	-145.40%	-145.40%	-366.80%	-
Return on Assets (ROA)	-73.40%	-73.40%	-65.70%	-
Return on Capital (ROIC)	-47.09%	-47.09%	-114.92%	-53.36%
Earnings Yield	-21.04%	-24.40%	-	-
FCF Yield	-13.60%	-16.09%	-	-
Buyback Yield / Dilution	-125.57%	-23.53%	-
Total Shareholder Return	-125.57%	-23.53%	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).